Urinary tract infection caused by antibiotic-resistant uropathogenic Escherichia coli: a major public health concern

Date
2021
Authors
Brito-Goulart, Débora
Major Professor
Advisor
Committee Member
Journal Title
Journal ISSN
Volume Title
Publisher
Research, Society and Development
Altmetrics
Authors
Brito-Goulart, Débora
Person
Graduate Student
Research Projects
Organizational Units
Journal Issue
Series
Department
Veterinary Microbiology and Preventive Medicine
Abstract
Urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) is one of the most prevalent bacterial infections and is a major cause of health-related morbidity and hospital costs worldwide. The rising bacterial resistance to routinely given antibiotics for infected individuals is becoming a significant source of concern. Current research shows that UPEC is becoming more resistant to multiple antibiotic classes, including fluoroquinolones, beta-lactams, and aminoglycosides, as a result of genetic determinants of resistance and multidrug-resistant clones. Knowledge of the local etiology and the sensitivity profile of the most common uropathogens to antibiotics should guide decisions in the empirical therapy of uncomplicated UTI. Given the high prevalence of UTI and multidrug-resistant bacteria, preventative measures such as the development of an efficient vaccination are essential. The current work is an integrated literature review that synthesizes information on UTIs caused by antibiotic-resistant uropathogenic E. coli and considers the practical implications of key research results.
Comments
This article is published as Goulart, Débora Brito. "Urinary tract infection caused by antibiotic-resistant uropathogenic Escherichia coli: a major public health concern." Research, Society and Development 10, no. 16 (2021): e34101623190-e34101623190. DOI: 10.33448/rsd-v10i16.23190. Copyright 2021 Débora Brito Goulart. Attribution 4.0 International (CC BY 4.0). Posted with permission.
Description
Keywords
Urinary tract infections, Uropathogenic Escherichia coli, Antibiotic resistance, Vaccines, Public health, Economic burden
Citation
DOI
Collections